32
BIOTECHNOLOGY VALUE FUND L P updates its Form D — $1.55B sold
Fund raise update · Hedge fund · Open-ended · Offering Indefinite · Sold $1.55B · SAN FRANCISCO, CA · filed 2025-12-23
32
BIOTECHNOLOGY VALUE FUND L P updates its Form D — $1.51B sold
Fund raise update · Hedge fund · Open-ended · SAN FRANCISCO, CA · Form D/A filed 2024-12-27 · all Biotechnology Value vehicles
$100M+ sold
Why now — by persona
Relevant to: Fund audit & tax, Fund administrator. Lead card pending.
People on the filing
| n/a BVF Inc. | Executive Officer |
| n/a N. BVF I GP LLC | General Partner |
| James N. Kratky | Chief Financial Officer, Chief Compliance Officer |
| n/a BVF Partners, L.P. | Investment Manager |
| n/a N. BVF GP Holdings LLC | Executive Officer |
| Mark N. Lampert | Chief Executive Officer |
| Jason N. McCune | Chief Operating Officer |
Signed by Mark N. Lampert, Chief Executive Officer of the General Partner.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.